Health Care Stocks Gain as Investors Shift
Operators tracking capital flows should note health care equities outpacing data-center holdings this week.
Updated on Nov. 7, 2026 in Healthcare

Jim Cramer's Charitable Trust plans to sell 50 Cardinal Health shares and 10 Eli Lilly shares, trimming two health care holdings that have risen more than 20% since late September. The trust would retain 375 Cardinal Health shares and 70 Eli Lilly shares after the sales.
Why it matters
The planned trades reflect a portfolio rebalance after strong gains in two large health care companies, with the trust citing diversification away from data-center stocks. For operators, it is a reminder that health care equities have recently outperformed technology holdings, a rotation that can shift capital and investor attention across sectors.
The trust would sell 50 Cardinal Health shares at about $273 each and 10 Eli Lilly shares at about $1,420 each, lowering portfolio weightings to 2.75% and 2.6% from 3% each. Realized gains would be 20% on the Cardinal Health shares, bought in March 2026, and 500% on the Eli Lilly shares, bought in February 2022.
The players
Cardinal Health
A large U.S. health care distribution company that moves pharmaceuticals and medical products from manufacturers to hospitals and pharmacies.
Eli Lilly
A major pharmaceutical manufacturer known for diabetes and obesity treatments, with significant scale in the global drug market.
Jim Cramer's Charitable Trust
A charitable trust associated with CNBC television personality Jim Cramer that holds a publicly reported stock portfolio.
The details
Selling a portion of a position locks in gains while keeping exposure to the company, a common rebalancing method when one holding grows to a larger share of a portfolio. Here the trust would keep 375 Cardinal Health shares and 70 Eli Lilly shares after the sales. Both stocks rose more than 20% since late September, and Cardinal Health gained more than 4% Thursday after stronger-than-expected earnings and a raised full-year outlook. Health care stocks outperformed Thursday as technology and data-center shares came under pressure.
Timeline
February 2022: Eli Lilly shares were bought, and 10 of them are now planned for sale.
March 2026: Cardinal Health shares were bought, and 50 of them are now planned for sale.
Late September 2026: Both stocks began a rally that has lifted them more than 20%.
Last week: Eli Lilly reported stronger-than-expected results and raised its outlook.
Thursday: Cardinal Health rose after earnings as the planned trades were reported.
Market Landscape
The trust's health care purchases and planned sales illustrate a broader rotation away from data-center and technology stocks that the stub describes as underway this week. Health care names have outperformed as investors reassess concentration in AI-linked infrastructure holdings.
Operators in health care distribution and pharmaceutical supply should note that investor attention is shifting toward the sector, which can affect access to capital and valuations. Businesses with exposure to these companies may wish to review how sector rotation could affect their own financing and supplier relationships with qualified financial advisers.
The takeaway
The rotation from data-center stocks into health care is a signal worth tracking for operators planning capital and supplier decisions. Watch the next quarterly filings from Cardinal Health and Eli Lilly for evidence of whether these sector gains hold.
Further reading
For more on the sector behind these holdings, see the Healthcare section of our coverage.
Source note: This article includes information reported by TokenPost.




